JOHN MITCHELL: Open Payments
NPI 1225024912 · BREA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$754 in 25 payments from 6 companies in 2025. Trend: 2023 $770 · 2024 $812 · 2025 $754
Food & beverage: $754
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 12 | $428 |
| ABBVIE INC. | 6 | $162 |
| Lilly USA, LLC | 4 | $87 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $30 |
| Antares Pharma, Inc. | 1 | $25 |
| Bausch Health US, LLC | 1 | $23 |
Products named: REPATHA, OTEZLA, UBRELVY, JARDIANCE, MOUNJARO, Kerendia, VRAYLAR, XYOSTED.
Industry payments across CA — which companies pay providers there.
